COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(22)00274-6
PubMed Identifier: 36088954
Publication URI: http://europepmc.org/abstract/MED/36088954
Type: Journal Article/Review
Volume: 7
Parent Publication: The lancet. Gastroenterology & hepatology
Issue: 11